Rothschild Investment LLC’s Genmab GMAB Stock Holding History

Rothschild Investment LLC’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66.9K	Sell	2,436 -78	-3%	-$2.07K	﹤0.01%	1177
2026 Q1	$67.5K	Sell	2,514 -41	-2%	-$1.23K	﹤0.01%	1034
2025 Q4	$78.7K	Buy	2,555 +17	+0.7%	+$530	﹤0.01%	884
2025 Q3	$77.8K	Buy	2,538 +1,792	+240%	+$43.7K	﹤0.01%	869
2025 Q2	$15.4K	Buy	746 +63	+9%	+$1.29K	﹤0.01%	1090
2025 Q1	$13.4K	Sell	683 -201	-23%	-$4.22K	﹤0.01%	1104
2024 Q4	$18.4K	Buy	884 +227	+35%	+$4.99K	﹤0.01%	1017
2024 Q3	$16K	Buy	657 +112	+21%	+$2.99K	﹤0.01%	1048
2024 Q2	$13.7K	Buy	545 +126	+30%	+$3.57K	﹤0.01%	1051
2024 Q1	$12.5K	Buy	419 +208	+99%	+$6.11K	﹤0.01%	1022
2023 Q4	$6.72K	Buy	+211	New	+$6.63K	﹤0.01%	1042

Other funds holding GMAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

LWAM

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Rothschild Investment LLC's GMAB Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Genmab (GMAB) stake by 3.1% in Q2 2026, selling an estimated $2.07K and leaving 2,436 shares worth $66.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

Rothschild Investment LLC first reported a position in GMAB in Q4 2023 and has held it in 11 quarters since. The position peaked at $78.7K in Q4 2025. 122 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Rothschild Investment LLC held 2,436 shares of Genmab worth $66.9K as of Q2 2026.
Rothschild Investment LLC sold 78 Genmab shares in Q2 2026, an estimated $2.07K.
Genmab made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1177 holding.
Rothschild Investment LLC first reported a position in Genmab in Q4 2023 and has held it in 11 quarters since.
Rothschild Investment LLC's Genmab position peaked at $78.7K in Q4 2025.
122 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.